Opportunities for Use of Blockchain Technology in Medicine.

abstract：OBJECTIVES:The objective of this study was to construct an early economic evaluation for acalabrutinib for relapsed chronic lymphocytic leukaemia (CLL) to assist early reimbursement decision making. Scenarios were assessed to find the relative impact of critical parameters on incremental costs and quality-adjusted life...

journal_title：Applied health economics and health policy

authors： Vreman RA,Geenen JW,Hövels AM,Goettsch WG,Leufkens HGM,Al MJ

更新日期：2019-12-01 00:00:00

abstract：BACKGROUND:Cervical cancer ranks fourth amongst the commonest malignancies worldwide and the second most prevalent cancer afflicting women in low-to-middle income countries (LMICs), hence, of great public health importance. LMICs are the most affected regions as evidenced by their high prevalence of the disease. Mortal...

journal_title：Applied health economics and health policy

authors： Okeah BO,Ridyard CH

更新日期：2020-10-01 00:00:00

abstract：BACKGROUND:As tuberculosis screening trends to targeting high-risk populations, knowing the cost effectiveness of such screening is vital to decision makers. OBJECTIVES:The purpose of this review was to compile cost-utility analyses evaluating latent tuberculosis infection (LTBI) screening in high-risk populations tha...

journal_title：Applied health economics and health policy

authors： Campbell JR,Sasitharan T,Marra F

更新日期：2015-08-01 00:00:00

abstract：BACKGROUND:The management of the large patient population in Italy receiving long-term oral anticoagulation therapy (OAT) poses organizational challenges that are traditionally approached with a centralized procedure, relying on hospital-based clinics and/or GPs. However, the availability of near-patient testing device...

journal_title：Applied health economics and health policy

authors： Pradelli L,Iannazzo S,Zaniolo O,Botrugno P

更新日期：2010-01-01 00:00:00

abstract：BACKGROUND:The clinical management of intracranial aneurysms is debated in many countries because of the associated disability risk and costs. Therefore, estimating the costs and explaining their variability will provide important information for decision makers. OBJECTIVE:We aimed to evaluate the acute and post-acute...

journal_title：Applied health economics and health policy

authors： Calciolari S,Torbica A,Tarricone R

更新日期：2013-08-01 00:00:00

abstract：BACKGROUND:The Xpert® MTB/RIF (Xpert) test has been shown to be effective and cost-effective for diagnosing tuberculosis (TB) under conditions with high HIV prevalence and HIV-TB co-infection but less is known about Xpert's cost in low HIV prevalence settings. Cambodia, a country with low HIV prevalence (0.7%), high TB...

journal_title：Applied health economics and health policy

authors： Pallas SW,Courey M,Hy C,Killam WP,Warren D,Moore B

更新日期：2018-08-01 00:00:00

abstract：OBJECTIVES:To analyse the cost effectiveness of community-based case management for patients suffering from chronic obstructive pulmonary disease (COPD). METHODS:The study took place in the third largest municipality in Denmark and was conducted as a randomised controlled trial with 12 months of follow-up. A total of ...

journal_title：Applied health economics and health policy

authors： Sørensen SS,Pedersen KM,Weinreich UM,Ehlers L

更新日期：2017-06-01 00:00:00

abstract：:The debate surrounding whether the findings of efficacy studies are applicable to real-world treatment situations is ongoing. The issue of lack of applicability due to a lack of clinical heterogeneity could be addressed by employing less restrictive inclusion criteria. Given that health economic assessments based on c...

journal_title：Applied health economics and health policy

authors： Richter A,Thieda P,Thaler K,Gartlehner G

更新日期：2011-05-01 00:00:00

abstract：OBJECTIVE:The main purpose of this study is to measure the technical efficiency of twenty health systems in the Middle East and North Africa (MENA) region to inform evidence-based health policy decisions. In addition, the effects of alternative stochastic frontier model specification on the empirical results are examin...

journal_title：Applied health economics and health policy

authors： Hamidi S,Akinci F

更新日期：2016-06-01 00:00:00

abstract：AIM:To assess the relative cost effectiveness of four strategies (academic detailing, computerised reminder systems, target payments and interactive continuing medical education) to increase the provision of screening and brief interventions by Australian GPs with the ultimate goal of decreasing risky alcohol consumpti...

journal_title：Applied health economics and health policy

authors： Shanahan M,Shakeshaft A,Mattick RP

更新日期：2006-01-01 00:00:00

abstract：BACKGROUND AND OBJECTIVES:Generic substitution has been introduced in most countries in order to reduce costs and improve access to drugs. However, regulations and the generic drugs available vary between countries. It is the prescriber or dispenser of the drug who is the final decision maker. Nevertheless, physicians'...

journal_title：Applied health economics and health policy

authors： Toverud EL,Hartmann K,Håkonsen H

更新日期：2015-08-01 00:00:00

abstract：OBJECTIVES:Invasive pneumococcal disease (IPD), pneumonia and acute otitis media (AOM) still represent a significant medical burden in children < 5 years of age in New Zealand (NZ), with marked disparities across socio-economic and ethnic groups. This cost-effectiveness evaluation aims to compare the potential impact o...

journal_title：Applied health economics and health policy

authors： Varghese L,Talbot L,Govender A,Zhang XH,Mungall BA

更新日期：2018-06-01 00:00:00

abstract：:Health state utility values are a major source of uncertainty in economic evaluations of interventions for age-related macular degeneration (AMD). This review identifies and critiques published utility values and methods for eliciting de novo utility values in AMD. We describe how utility values have been used in heal...

journal_title：Applied health economics and health policy

authors： Butt T,Tufail A,Rubin G

更新日期：2017-02-01 00:00:00

abstract：BACKGROUND:The Patient Protection and Affordable Care Act instituted pay-for-performance programs, including Hospital Value-Based Purchasing (HVBP), designed to encourage hospital quality and efficiency. OBJECTIVE AND METHOD:While these programs have been evaluated with respect to their implications for care quality a...

journal_title：Applied health economics and health policy

authors： Izón GM,Pardini CA

更新日期：2018-02-01 00:00:00

abstract：BACKGROUND:Treatment with antipsychotic medication is an important element of relapse prevention in the management of schizophrenia, and can reduce inpatient stays. Recently, the long-acting atypical antipsychotic paliperidone long-acting injectable (PLAI), a once-monthly LAI antipsychotic, was approved for treatment o...

journal_title：Applied health economics and health policy

authors： Zeidler J,Mahlich J,Greiner W,Heres S

更新日期：2013-10-01 00:00:00

abstract：OBJECTIVES:To describe how post-market utilisation analysis in Australia informs cost-effectiveness assessment and pricing decisions, using aflibercept and ranibizumab as case studies. METHODS:Pharmaceutical claims were used to identify initiators of aflibercept and ranibizumab in the year after aflibercept-listing (D...

journal_title：Applied health economics and health policy

authors： Kemp-Casey A,Pratt N,Ramsay E,Roughead EE

更新日期：2019-06-01 00:00:00

abstract：:This article aims to define a value-based approach to pricing and reimbursement for off-patent originators using a multiple criteria decision analysis (MCDA) approach centered on a systematic analysis of current pricing and reimbursement policies in China. A drug price policy review was combined with a quantitative an...

journal_title：Applied health economics and health policy

authors： Hu S,Zhang Y,He J,Du L,Xu M,Xie C,Peng Y,Wang L

更新日期：2015-08-01 00:00:00

abstract：BACKGROUND:Limited empirical evidence exists regarding the effect of price changes on hospital behavior and, ultimately, the quality of care. Additionally, an overview of the results of prior literature is lacking. OBJECTIVE:This study aims to provide a synthesis of existing research concerning the relationship betwee...

journal_title：Applied health economics and health policy

authors： Jamalabadi S,Winter V,Schreyögg J

更新日期：2020-10-01 00:00:00

abstract：:Central venous catheters are commonly used to deliver therapies and to monitor patients, and require securing at the point of percutaneous entry to avoid dislodgement. SecurAcath is a catheter securement device designed for central venous catheters. The National Institute for Health and Care Excellence, as a part of i...

journal_title：Applied health economics and health policy

authors： Macmillan T,Pennington M,Summers JA,Goddard K,Zala D,Herz N,Peacock JL,Keevil S,Chalkidou A

更新日期：2018-12-01 00:00:00

abstract：:Payment incentives to both consumers and providers have significant consequences for the equity and efficiency of a healthcare system, and have recently come to the fore in health policy reforms. This review first discusses the economic rationale for the apparent international convergence toward payment systems with m...

journal_title：Applied health economics and health policy

authors： Eggleston K,Hsieh CR

更新日期：2004-01-01 00:00:00

abstract：INTRODUCTION:From 2000 to 2004, primary care organisations (PCOs) in England were legally required to operate a prescribing incentive scheme for their general practices. A statutory framework specified the types of target, maximum rewards and use of 'good cause for failure' provisions that schemes should include. Our o...

journal_title：Applied health economics and health policy

authors： Mason AR,Drummond MF,Hunter JA,Towse AK,Cooke J

更新日期：2005-01-01 00:00:00

abstract：CONTEXT:The in-hospital costs of extracorporeal membrane oxygenation (ECMO) have not been well established. OBJECTIVE:To evaluate the in-hospital costs of ECMO technology in both US and non-US settings for all patient types. DATA SOURCES:Systematic review of English-language articles, using the PubMed, Embase, Web of...

journal_title：Applied health economics and health policy

authors： Harvey MJ,Gaies MG,Prosser LA

更新日期：2015-08-01 00:00:00

abstract：:The aim of the review is to establish whether, on the basis of previous published evidence, current accepted guidance for health economic evaluation needs to be adapted to evaluate healthcare based on use of genetic information. Online literature search strategies were designed (using PubMed and the NHS Economic Evalu...

journal_title：Applied health economics and health policy

authors： Jarrett J,Mugford M

更新日期：2006-01-01 00:00:00

abstract：BACKGROUND:Conventional intraoperative sentinel lymph node biopsy (SLNB) in breast cancer (BC) has limitations in establishing a definitive diagnosis of metastasis intraoperatively, leading to an unnecessary second operation. The one-step nucleic amplification assay (OSNA) provides accurate intraoperative diagnosis and...

journal_title：Applied health economics and health policy

authors： Saruta Y,Puig-Junoy J

更新日期：2016-06-01 00:00:00

abstract：:The biotech industry now accounts for a substantial and growing proportion of total R&D spending on new medicines. However, compared with the pharmaceutical industry, the biotech industry is financially fragile. This article illustrates the financial fragility of the biotech and pharmaceutical industries in the US and...

journal_title：Applied health economics and health policy

authors： Golec J,Vernon JA

更新日期：2009-01-01 00:00:00

abstract：:Economic models are developed to provide decision makers with information related to the real-world effectiveness of therapeutics, screening and diagnostic regimens. Although compliance with these regimens often has a significant impact on real-world clinical outcomes and costs, compliance and persistence have histori...

journal_title：Applied health economics and health policy

authors： Kadambi A,Leipold RJ,Kansal AR,Sorensen S,Getsios D

更新日期：2012-11-01 00:00:00

abstract：BACKGROUND:Liposomal amphotericin B (L-AMB) and amphotericin B lipid complex (ABLC) are both indicated for treating invasive fungal infections (IFIs) caused by Aspergillus, Candida and Cryptococcus spp. among patients who are refractory to or intolerant of conventional amphotericin B (CAB). Prior studies have suggested...

journal_title：Applied health economics and health policy

authors： Yang H,Chaudhari P,Zhou ZY,Wu EQ,Patel C,Horn DL

更新日期：2014-02-01 00:00:00

abstract：:Despite recent initiatives across a number of countries to institutionalise the use of economic evaluation in the assessment of new technologies, the evidence suggests that, to date, the impact of economic analysis on health sector decision making in practice has been low. This paper proposes that incentive compatibil...

journal_title：Applied health economics and health policy

authors： Jan S

更新日期：2003-01-01 00:00:00

abstract：BACKGROUND:Community-based health insurance (CBHI) schemes have been introduced in low- and middle-income countries to increase health service utilization and provide financial protection from high healthcare expenditures. OBJECTIVE:We assess the impact of household size on decisions to enroll in CBHI and demonstrate ...

journal_title：Applied health economics and health policy

authors： Ozawa S,Grewal S,Bridges JF

更新日期：2016-04-01 00:00:00

abstract：BACKGROUND:Canadian patients, healthcare providers and payers share interest in assessing the value of self-monitoring of blood glucose (SMBG) for individuals with type 2 diabetes but not on insulin. Using the UKPDS (UK Prospective Diabetes Study) model, the Canadian Optimal Prescribing and Utilization Service (COMPUS)...

journal_title：Applied health economics and health policy

authors： Tunis SL

更新日期：2011-11-01 00:00:00